JPRN-UMIN000001286已完成1 期
clinical trial of CHP-HER2 cancer vaccine with immuno-adjuvant, OK-432, for advanced breast cancer - CHP-HER2 vaccine for advanced breast cancer
Mie University, University of Ocupational and Environmental Health, Nagasaki University, National Hospital Organization Saga National Hospital, Hamamatsu Medical Center0 个研究点目标入组 20 人开始时间: 2008年8月2日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Previous uses of trastuzumab(Herceptin). Uncontrolled heart failure. Impaired cardiac function, 50% or less of ejection fraction. Uncontrolled arrythmia. Uncontrolled hypertention. Angina pectoris, cardiac valvular disease. Pulmonary fibrosis. Uncontrolled diabetes mellitus. Antibody-requiring active infection. Blood clotting disorder. Positive for HBV, HIV or HTLV-1, except HBV healthy carrier and negatives for HCVmRNA. History of penicillin allergy. Ongoing corticosteroid therapy. Pregnancy Willing to be pregnant. Inappropriate for study entry judged by an attending physician.
研究者
相似试验
已完成
不适用
A phase I clinical trial of cancer vaccine using multiple antigen epitope peptides for advanced cervical canceradvanced and recurrent cervical cancerJPRN-UMIN000003999Saitama medical university international medical center18
已完成
2 期
A phase II clinical study of cancer vaccine with Survivin helper peptide for patients with advanced/recurrent colorectal cancersSurvivin-expressing advanced/recurrent colorectal cancer patients or patients who refuse standard cancer therapyJPRN-UMIN000007506Department of Gastroenterological Surgery I, Hokkaido University Graduated School of Medicine35
已完成
2 期
A phase II clinical study of cancer vaccine with Survivin helper peptide for patients with advanced/recurrent breast cancersA phase II clinical study of cancer vaccine with Survivin helper peptide for patients with advanced/recurrent breast cancersJPRN-UMIN000007507Department of Breast and Endocrine Surgery, Hokkaido University Hospital40
已完成
1 期
The phase I,II clinical study of cancer vaccine for intractable malignant tumor expressing MAGE-A4-antigeIntractable malignant tumors expressing MAGE-A4 antigenJPRN-UMIN000001999Department of Surgical Oncology, Hokkaido University Graduate School of Medicine18
招募中
2 期
Clinical trial of therapeutic vaccine against HBV carriers without anti-HBV treatmentchronic hepatitis BD019694JPRN-jRCTs061210087Hiasa Yoichi200